February 13, 2018 / 1:26 PM / 7 months ago

BRIEF-Pain Therapeutics Resubmits New Drug Application For Remoxy ER

Feb 13 (Reuters) - Pain Therapeutics Inc:

* PAIN THERAPEUTICS RESUBMITS NEW DRUG APPLICATION FOR REMOXY® ER, AN ABUSE-DETERRENT, EXTENDED-RELEASE DRUG CANDIDATE FOR THE TREATMENT OF CHRONIC PAIN

* PAIN THERAPEUTICS INC - COMPANY EXPECTS A SIX-MONTH REVIEW CYCLE BY FDA FOR REMOXY NDA

* PAIN THERAPEUTICS INC - EXPECTS TO BE NOTIFIED BY FDA OF A PRESCRIPTION DRUG USER FEE ACT (PDUFA) DATE WITHIN 60 DAYS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below